Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
about
Predictive role of HER2/neu, topoisomerase-II-alpha, and tissue inhibitor of metalloproteinases (TIMP-1) for response to adjuvant taxane-based chemotherapy in patients with intermediate-risk breast cancer: results from the WSG-AGO EC-Doc trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@en
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@nl
type
label
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@en
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@nl
prefLabel
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@en
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@nl
P2093
P2860
P1476
Predictive role of HER2/neu, t ...... from the WSG-AGO EC-Doc trial.
@en
P2093
Annette Bartels
Arndt Hartmann
Christoph Thomssen
Cornelia Liedtke
Doris Augustin
Enrico Pelz
Fritz Jänicke
Hans Heinrich Kreipe
Jens Huober
Marion Kiechle
P2860
P2888
P304
P356
10.1007/S10549-015-3310-X
P407
P577
2015-02-28T00:00:00Z
P6179
1003726965